- Home
- QNCX vs UFI Comparison
QNCX vs UFI Comparison
Compare QNCX & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- UFI
- Stock Information
- Founded
- QNCX 2012
- UFI 1969
- Country
- QNCX United States
- UFI United States
- Employees
- QNCX N/A
- UFI N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- UFI Textiles
- Sector
- QNCX Health Care
- UFI Consumer Discretionary
- Exchange
- QNCX Nasdaq
- UFI Nasdaq
- Market Cap
- QNCX 100.4M
- UFI 84.6M
- IPO Year
- QNCX 2019
- UFI N/A
- Fundamental
- Price
- QNCX $1.98
- UFI $4.64
- Analyst Decision
- QNCX Strong Buy
- UFI
- Analyst Count
- QNCX 6
- UFI 0
- Target Price
- QNCX $8.00
- UFI N/A
- AVG Volume (30 Days)
- QNCX 431.7K
- UFI 46.2K
- Earning Date
- QNCX 11-12-2025
- UFI 10-29-2025
- Dividend Yield
- QNCX N/A
- UFI N/A
- EPS Growth
- QNCX N/A
- UFI N/A
- EPS
- QNCX N/A
- UFI N/A
- Revenue
- QNCX N/A
- UFI $571,344,000.00
- Revenue This Year
- QNCX N/A
- UFI $9.98
- Revenue Next Year
- QNCX N/A
- UFI $5.75
- P/E Ratio
- QNCX N/A
- UFI N/A
- Revenue Growth
- QNCX N/A
- UFI N/A
- 52 Week Low
- QNCX $0.71
- UFI $4.25
- 52 Week High
- QNCX $2.45
- UFI $7.55
- Technical
- Relative Strength Index (RSI)
- QNCX 62.46
- UFI 50.42
- Support Level
- QNCX $1.82
- UFI $4.58
- Resistance Level
- QNCX $2.01
- UFI $4.78
- Average True Range (ATR)
- QNCX 0.16
- UFI 0.17
- MACD
- QNCX 0.03
- UFI -0.01
- Stochastic Oscillator
- QNCX 64.48
- UFI 67.92
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.